Leap Therapeutics, Inc.
LPTX
$0.3634
-$0.0056-1.52%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -67.79M | -64.59M | -60.11M | -53.37M | -81.41M |
| Total Depreciation and Amortization | 5.00K | 9.00K | 12.00K | 16.00K | 15.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.20M | 4.70M | 5.15M | 5.25M | 35.14M |
| Change in Net Operating Assets | 1.29M | 4.71M | 4.89M | 1.54M | 2.51M |
| Cash from Operations | -60.30M | -55.17M | -50.06M | -46.57M | -43.75M |
| Capital Expenditure | -- | 0.00 | 0.00 | -348.00K | -1.39M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | 0.00 | 50.36M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 0.00 | 0.00 | -348.00K | 48.97M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 40.13M | 40.03M | 40.03M | 29.00K | -- |
| Repurchase of Common Stock | -- | 0.00 | -1.00K | -1.00K | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.95M | -2.95M | -2.88M | 0.00 | -29.00K |
| Cash from Financing | 37.18M | 37.08M | 37.15M | 28.00K | -30.00K |
| Foreign Exchange rate Adjustments | -279.00K | 167.00K | -26.00K | -228.00K | -43.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.39M | -17.92M | -12.94M | -47.12M | 5.14M |